Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
China National Clinical Research Center for Neurological Diseases, Beijing, China.
Aging (Albany NY). 2021 Dec 8;13(23):25106-25137. doi: 10.18632/aging.203730.
Identifying a unique and common regulatory pathway that drives tumorigenesis in cancers is crucial to foster the development of effective treatments. However, a systematic analysis of fatty acid synthase across pan-cancers has not been carried out.
We investigated the oncogenic roles of fatty acid synthase in 33 cancers based on the cancer genome atlas and gene expression omnibus.
Fatty acid synthase is profoundly expressed in most cancers and is an important factor in predicting the outcome of cancer patients. Further, the level of S207 phosphorylation was found to be improved in several neoplasms (e.g., colon cancer). Fatty acid synthase expression is related to tumor-infiltrating immune cells in tumors (e.g., CD8+ T-cell infiltration level in cervical squamous cell carcinoma). Moreover, hormone receptor binding- and fatty acid metabolic process-associated pathways are involved in the functional mechanisms of fatty acid synthase.
This study provides a complete understanding of the oncogenic role of fatty acid synthase in human tumors.
确定驱动癌症发生的独特和共同的调控途径对于促进有效治疗的发展至关重要。然而,脂肪酸合酶在泛癌症中的系统分析尚未进行。
我们基于癌症基因组图谱和基因表达综合数据库,研究了脂肪酸合酶在 33 种癌症中的致癌作用。
脂肪酸合酶在大多数癌症中表达深刻,是预测癌症患者预后的重要因素。此外,在几种肿瘤中(例如结肠癌)发现 S207 磷酸化水平得到改善。脂肪酸合酶的表达与肿瘤浸润免疫细胞有关(例如,宫颈鳞状细胞癌中的 CD8+T 细胞浸润水平)。此外,激素受体结合和脂肪酸代谢过程相关途径参与了脂肪酸合酶的功能机制。
本研究提供了对脂肪酸合酶在人类肿瘤中致癌作用的全面理解。